Greg Kulnis joins Nexelis as a Vice President, Customer Solutions for Infectious Disease with the goal of synchronizing the operation and commercial organizations to enhance the customer experience. He joins from a commercial role at Covance where he supported the global business development efforts for their Vaccine and Novel Immunotherapeutic Lab. Greg began his career in the Clinical Assay Research and Development group of Merck Research Labs where he supported the development of multiple licensed vaccines and the various assay methodologies needed to support that licensure. Greg also served as the Subject Matter Expert for Molecular Biology at PPD Vaccine and Biologics following the divestiture of the Wayne, PA labs to the PPD organization where he worked with various clients.